- Home
- WLK vs SNN Comparison
WLK vs SNN Comparison
Compare WLK & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLK
- SNN
- Stock Information
- Founded
- WLK 1986
- SNN 1856
- Country
- WLK United States
- SNN United Kingdom
- Employees
- WLK N/A
- SNN N/A
- Industry
- WLK Major Chemicals
- SNN Industrial Specialties
- Sector
- WLK Industrials
- SNN Health Care
- Exchange
- WLK Nasdaq
- SNN Nasdaq
- Market Cap
- WLK 13.8B
- SNN 12.3B
- IPO Year
- WLK 2004
- SNN 1999
- Fundamental
- Price
- WLK $100.05
- SNN $28.37
- Analyst Decision
- WLK Buy
- SNN Hold
- Analyst Count
- WLK 14
- SNN 3
- Target Price
- WLK $136.07
- SNN $27.00
- AVG Volume (30 Days)
- WLK 877.6K
- SNN 747.4K
- Earning Date
- WLK 04-30-2025
- SNN 02-25-2025
- Dividend Yield
- WLK 2.09%
- SNN 2.65%
- EPS Growth
- WLK 25.41
- SNN 56.15
- EPS
- WLK 4.64
- SNN 0.47
- Revenue
- WLK $12,142,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- WLK $3.32
- SNN $6.42
- Revenue Next Year
- WLK $6.41
- SNN $5.03
- P/E Ratio
- WLK $21.36
- SNN $29.40
- Revenue Growth
- WLK N/A
- SNN 4.70
- 52 Week Low
- WLK $97.37
- SNN $23.65
- 52 Week High
- WLK $162.64
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- WLK 36.64
- SNN 52.49
- Support Level
- WLK $100.07
- SNN $27.89
- Resistance Level
- WLK $103.19
- SNN $28.71
- Average True Range (ATR)
- WLK 3.15
- SNN 0.43
- MACD
- WLK -0.32
- SNN -0.19
- Stochastic Oscillator
- WLK 19.91
- SNN 25.12
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.